What Ensign Group stock offers investors today

With no single headline event driving attention to Ensign Group (ENSG), the stock is drawing interest for its track record in skilled nursing and senior living services alongside recent share price moves.

Recent trading has been mixed, with the 1 day share price return of 3.66% contrasting with a 90 day share price return that is down 18.89%, while the 5 year total shareholder return of 104.14% points to strong longer term compounding. Overall, short term momentum looks softer compared with the longer term record.

If you are reassessing your watchlist after Ensign Group's recent moves, this can be a useful moment to broaden your search and uncover 20 top founder-led companies

The stock currently trades at $170.30, with mixed recent returns and a value score of 1. This raises a key question for you: is Ensign Group quietly offering value, or is the market already pricing in its future growth?

Price-to-Earnings of 27.2x: Is it justified?

Ensign Group trades on a P/E of 27.2x, which sits above several benchmarks and suggests investors are currently paying a premium for each dollar of earnings.

The P/E ratio compares the share price to earnings per share, so it effectively shows how much you are paying today for the company’s current earnings power. For a healthcare services provider where earnings and cash flow matter more than story alone, a higher P/E often reflects expectations for continued profit growth and business resilience.

In Ensign Group's case, that 27.2x multiple is higher than both the peer average of 13.9x and the US Healthcare industry average of 23.8x. This means the stock trades at a clear premium to similar companies. It is also above an estimated fair P/E of 23.3x. The market could move towards this level if sentiment or growth expectations cool from here.

Result: Price-to-Earnings of 27.2x (OVERVALUED)

However, slower recent share price performance and a P/E above both peers and an estimated fair level could leave the stock exposed if sentiment or earnings expectations soften.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another view on value: DCF says slightly overvalued

While the P/E screen flags Ensign Group as expensive, the SWS DCF model paints a more muted picture. On this approach, the stock at $170.30 sits just above an estimated future cash flow value of $164.13, suggesting only a mild premium. This raises the question of whether this is a margin of safety issue or simply noise around fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ensign Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of rich valuation and recent share price softness leaves you unsure, do not wait for consensus to form. Instead, review the 3 key rewards

Looking for more investment ideas?

Before moving on, give yourself a real edge by scanning for fresh opportunities that match your style, instead of waiting for ideas to reach the headlines.

• Target quality at a discount by checking companies flagged as 49 high quality undervalued stocks to see which ones line up with your return and risk expectations.
• Prioritize resilience by focusing on businesses in the solid balance sheet and fundamentals stocks screener (46 results) if you want stronger financial footing to anchor your portfolio.
• Stay ahead of the crowd by reviewing the screener containing 21 high quality undiscovered gems before other investors start paying attention to these under-the-radar opportunities.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.